CTR20262786 clinical trial report covering KH-607, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600128388 clinical trial report covering Fulzerasib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07714746 clinical trial report covering Ivabradine Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07714525 clinical trial report covering Triamcinolone Acetonide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600128435 clinical trial report covering Rupatifen fumarate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07712913 clinical trial report covering Pregabalin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07714070 clinical trial report covering Orlistat, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07713745 clinical trial report covering Serplulimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07715565 clinical trial report covering Ipilimumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07715279 clinical trial report covering Vericiguat, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07714668 clinical trial report covering SYS6041, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07715084 clinical trial report covering Nizubaglustat, Phase 2, endpoints, sponsor, geography, readout timing and development white space.